131 related articles for article (PubMed ID: 8554933)
21. Pharmacokinetics of inhaled salbutamol in patients with cystic fibrosis versus healthy young adults.
Vaisman N; Koren G; Goldstein D; Canny GJ; Tan YK; Soldin S; Pencharz P
J Pediatr; 1987 Dec; 111(6 Pt 1):914-7. PubMed ID: 3681561
[TBL] [Abstract][Full Text] [Related]
22. The relative potencies and beta2-selectivities of intravenous rimiterol, salbutamol and isoprenaline in asthmatic patients.
Marlin GE; Turner P
Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):158-69. PubMed ID: 240780
[TBL] [Abstract][Full Text] [Related]
23. The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis.
Jartti T; Kaila T; Tahvanainen K; Kuusela T; Vanto T; Välimäki I
Br J Clin Pharmacol; 1997 Apr; 43(4):421-8. PubMed ID: 9146855
[TBL] [Abstract][Full Text] [Related]
24. Salbutamol disposition and dynamics in conscious rabbits: influence of the route of administration and of the dose.
Perreault S; Ong H; du Souich P
J Pharmacokinet Biopharm; 1992 Oct; 20(5):461-76. PubMed ID: 1287197
[TBL] [Abstract][Full Text] [Related]
25. Inhaled salbutamol and endurance cycling performance in non-asthmatic athletes.
van Baak MA; de Hon OM; Hartgens F; Kuipers H
Int J Sports Med; 2004 Oct; 25(7):533-8. PubMed ID: 15459835
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans.
Boulton DW; Fawcett JP
Clin Pharmacol Ther; 1997 Aug; 62(2):138-44. PubMed ID: 9284849
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol.
Windom H; Grainger J; Burgess C; Crane J; Pearce N; Beasley R
N Z Med J; 1990 Jun; 103(891):259-61. PubMed ID: 1972557
[TBL] [Abstract][Full Text] [Related]
28. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
Mohammed SP; Taylor CV; Weyman-Jones CB; Mather ME; Vendy K; Dougall IG; Young A
Pulm Pharmacol Ther; 2000; 13(6):287-92. PubMed ID: 11061983
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of salbutamol differs between asthmatic patients and healthy volunteers.
Naidu Sjöswärd K; Josefsson M; Ahlner J; Andersson RG; Schmekel B
Pharmacol Toxicol; 2003 Jan; 92(1):27-32. PubMed ID: 12710594
[TBL] [Abstract][Full Text] [Related]
30. Inhaled beta-agonists improve lung function but not maximal exercise capacity in cystic fibrosis.
Dodd JD; Barry SC; Daly LE; Gallagher CG
J Cyst Fibros; 2005 May; 4(2):101-5. PubMed ID: 15978535
[TBL] [Abstract][Full Text] [Related]
31. Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of use.
Pichon A; Venisse N; Krupka E; Pérault-Pochat MC; Denjean A
Int J Sports Med; 2006 Mar; 27(3):187-92. PubMed ID: 16541373
[TBL] [Abstract][Full Text] [Related]
32. SULT 1A3 single-nucleotide polymorphism and the single dose pharmacokinetics of inhaled salbutamol enantiomers: are some athletes at risk of higher urine levels?
Jacobson GA; Yee KC; Wood-Baker R; Walters EH
Drug Test Anal; 2015 Feb; 7(2):109-13. PubMed ID: 24692077
[TBL] [Abstract][Full Text] [Related]
33.
Escher A; Kieninger E; Groof S; Savas ST; Schneiter M; Tschanz SA; Frenz M; Latzin P; Casaulta C; Müller L
J Aerosol Med Pulm Drug Deliv; 2023 Aug; 36(4):171-180. PubMed ID: 37196208
[No Abstract] [Full Text] [Related]
34. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
Tsukioka K; Nakamata M; Kondo A; Hashimoto T
Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
[TBL] [Abstract][Full Text] [Related]
35. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
[TBL] [Abstract][Full Text] [Related]
36. Determination of salbutamol enantiomers in human plasma and urine by chiral high-performance liquid chromatography.
Boulton DW; Fawcett JP
J Chromatogr B Biomed Appl; 1995 Oct; 672(1):103-9. PubMed ID: 8590921
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and effects of formoterol fumarate in healthy human subjects after oral dosing.
van den Berg BT; Braat MC; van Boxtel CJ
Eur J Clin Pharmacol; 1998 Aug; 54(6):463-8. PubMed ID: 9776436
[TBL] [Abstract][Full Text] [Related]
38. Effect of salbutamol on muscle strength and endurance performance in nonasthmatic men.
van Baak MA; Mayer LH; Kempinski RE; Hartgens F
Med Sci Sports Exerc; 2000 Jul; 32(7):1300-6. PubMed ID: 10912897
[TBL] [Abstract][Full Text] [Related]
39. Salbutamol Residues in Plasma, Urine and Hair of Heifers After a Single Dose and Throughout.
Zhang K; Liang X; Su C; Tang C; Zhao Q; Zhang J; Meng Q
J Anal Toxicol; 2016 Jul; 40(6):454-9. PubMed ID: 27165803
[TBL] [Abstract][Full Text] [Related]
40. Influence of hypoxia and hypercapnia on the kinetics and hypokaliaemic effect of salbutamol in the rabbit.
Perreault S; Saunier C; Ong H; Du Souich P
Xenobiotica; 1995 Mar; 25(3):271-81. PubMed ID: 7618353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
